RecruitingNot ApplicableNCT05129228

Optical Coherence Tomography of the Saphenous Vein Graft

Intraoperative Optical Coherence Tomography of the Saphenous Vein Conduit in Patients Undergoing Coronary Artery Bypass Surgery

Sponsor

St. Francis Hospital, New York

Enrollment

760 participants

Start Date

Apr 4, 2022

Study Type

INTERVENTIONAL

Conditions

Coronary Bypass Graft Stenosis

Summary

OCTOCAB is a prospective, randomized (1:1), single-center trial. The purpose of this study is to determine whether intravascular optical coherence tomography (OCT) guided saphenous vein grafting in coronary artery bypass surgery will reduce the rate of early vein graft failure (VGF).

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study uses a special imaging tool (optical coherence tomography, like a high-resolution camera inside blood vessels) to examine vein grafts placed during heart bypass surgery, to understand how well they're working. **You may be eligible if...** - You are 18 years old or older - You have signs of reduced blood flow to your heart (angina, silent ischemia, unstable angina, or a heart attack) - You are scheduled for elective bypass surgery (CABG) and at least one vein graft is planned - You can provide written informed consent **You may NOT be eligible if...** - You had a major heart attack (STEMI) within the last 24 hours Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEOCT-guided saphenous vein CABG

OCT examination of harvested saphenous vein conduits will indicate pathology. Under the surgeon's discretion the conduit segments with pathology will not be grafted.

Locations(1)

St Francis Hospital

Roslyn, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05129228